loaderimg
image

Coramaze Technologies develops the Tripair, a device repairing functional Tricuspid Regurgitation (fTR) in heart failure patients, to improve quality of life and reduce morbidity. The Tripair implant is anchored a-traumatically in the right atrium, enabling full retrievability and intra-procedural efficacy evaluation.

Company’s Keywords:

medical devices, cardiovascular medical technology, transcatheter mitral valve repair, structural heart valve diseases

Q How Many Employees Does This Company Have?

<15

Q Which Industry Does This Company Belong To?

Q What Is the Annual Income?

<3200000

Q What Is the Technology of All the Company’s Website?

Q What Year Was the Company Founded?

<2013

Rate us and Write a Review

Your review is recommended to be at least 140 characters long

image

building Own or work here? Claim Now! Claim Now!

imageYour request has been submitted successfully.

image